Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer
Open Access
Abstract
We aimed to explore the genetic and environmental contributions to variation in the risk of hematologic malignancies and characterize familial dependence within and across hematologic malignancies. The study base included 316,397 individual twins from the Nordic Twin Study of Cancer with a median of 41 years of follow-up: 88,618 (28%) of the twins were monozygotic, and 3459 hematologic malignancies were reported. We estimated the cumulative incidence by age, familial risk, and genetic and environmental variance components of hematologic malignancies accounting for competing risk of death. The lifetime risk of any hematologic malignancy was 2.5% (95% CI 2.4–2.6%), as in the background population. This risk was elevated to 4.5% (95% CI 3.1–6.5%) conditional on hematologic malignancy in a dizygotic co-twin and was even greater at 7.6% (95% CI 4.8–11.8%) if a monozygotic co-twin had a hematologic malignancy. Heritability of the liability to develop any hematologic malignancy was 24% (95% CI 14–33%). This estimate decreased across age, from approximately 55% at age 40 to about 20–25% after age 55, when it seems to stabilize. In this largest ever studied twin cohort with the longest follow-up, we found evidence for familial risk of hematologic malignancies. The discovery of decreasing familial predisposition with increasing age underscores the importance of cancer surveillance in families with hematological malignancies.Keywords
Funding Information
- Nordic Cancer Union (Genetic Epidemiology and Familial Risk of Cross-Cancer Associations: A Nordic Twin Study)
- The AgeCare program of the Academy of Geriatric Cancer Research, Odense University Hospital (-)
- Scholarship from the Faculty of Health Sciences, University of Southern Denmark (-)
This publication has 36 references indexed in Scilit:
- NORDCAN – a Nordic tool for cancer information, planning, quality control and researchActa Oncologica, 2010
- Tattoo pigment in two lymph nodes in a patient with melanomaJournal of the European Academy of Dermatology and Venereology, 2007
- Potential diagnostic pitfalls in melanoma arising in a cutaneous tattooHistopathology, 2007
- Multiple myeloma: A review of the epidemiologic literatureInternational Journal of Cancer, 2007
- Family history of hematopoietic and non-hematopoietic malignancies and risk of non-Hodgkin lymphomaCancer Causes & Control, 2007
- Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)Blood, 2006
- Non-Hodgkin's Lymphoma and Family History of Hematologic MalignancyAmerican Journal of Epidemiology, 2006
- Family History of Hematopoietic Malignancy and Risk of LymphomaJNCI: Journal of the National Cancer Institute, 2005
- Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer DatabaseBlood, 2005
- Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer ProbandsJNCI: Journal of the National Cancer Institute, 1994